{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:45:30Z","timestamp":1762508730477},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Nosocomial pneumonia (NP) remains a costly complication of hospitalization fraught with subsequent complications and augmented resource utilization. Consisting of ventilated hospital-acquired bacterial pneumonia (vHABP), nonventilated hospital-acquired bacterial pneumonia (nvHABP), and ventilator-associated bacterial pneumonia (VABP), each may respond differently to inappropriate empiric treatment (IET). We explored whether IET affects the three pneumonia types differently.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>A multicenter, retrospective cohort study within the Premier Research database.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Acute care hospitals in the United States.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients with three types of NP were identified based on a previously published <jats:italic toggle=\"yes\">International Classification of Diseases<\/jats:italic>, 9th Edition\/<jats:italic toggle=\"yes\">International Classification of Diseases<\/jats:italic>, 10th Edition Clinical Modification algorithm.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>We compared the impact of IET on hospital costs, length of stay (LOS), and development of <jats:italic toggle=\"yes\">Clostridium difficile<\/jats:italic> infection (CDI), extubation failure (EF), and reintubation (RT). Marginal effects were derived from multivariable regression analyses. IET was present if no drug covering the organism recovered from the index culture was administered within 2 days of the culture date. Among 17,819 patients who met the enrollment criteria, 26.5% had nvHABP, 25.6% vHABP, and 47.9% VABP. Compared with non-IET, IET was associated with increased mean unadjusted hospital LOS across all NP types: nvHABP 12.5 versus 21.1, vHABP 16.7 versus 19.2, and VABP 18.6 versus 21.4 days. The adjusted marginal hospital LOS (4.9 d) and costs ($13,147) with IET were the highest in nvHABP. Incident CDI was rare and similar across NP types (2.4% nvHABP to 3.6% VABP). Both EF and RT were more common with IET in VABP (EF, 15.4% vs 19.2%; RT, 6.2% vs 10.4%), but not vHABP (EF, 15.1% vs 17.7%; RT, 8.1% vs 9.1%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Although IET is relatively uncommon, it affects resource utilization and the risk of complications differently across NP types. The impact of IET is greatest on both LOS and costs in nvHABP and is greater on VABP than vHABP in terms of EF and RT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000667","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T18:01:39Z","timestamp":1649354499000},"page":"e0667","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014\u20132019"],"prefix":"10.1097","volume":"4","author":[{"given":"Marya D.","family":"Zilberberg","sequence":"first","affiliation":[{"name":"Health Services Research, EviMed Research Group, LLC, Goshen, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian H.","family":"Nathanson","sequence":"additional","affiliation":[{"name":"Biostatistics, OptiStatim, LLC, Longmeadow, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Puzniak","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Merck & Co., Inc., Kenilworth, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noah W. D.","family":"Zilberberg","sequence":"additional","affiliation":[{"name":"Health Services Research, EviMed Research Group, LLC, Goshen, MA."},{"name":"Engineering, Universty of Massachusetts, Amherst, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew F.","family":"Shorr","sequence":"additional","affiliation":[{"name":"Engineering, Universty of Massachusetts, Amherst, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/CMR.00051-05","article-title":"Ventilator-associated pneumonia: Diagnosis, treatment, and prevention.","volume":"19","author":"Koenig","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.122.1.262","article-title":"Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.","volume":"122","author":"Iregui","year":"2002","journal-title":"Chest"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1378\/chest.08-0842","article-title":"Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: A single-center experience.","volume":"134","author":"Zilberberg","year":"2008","journal-title":"Chest"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.00851-07","article-title":"Health care-associated pneumonia and community-acquired pneumonia: A single-center experience.","volume":"51","author":"Micek","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1186\/s13054-014-0596-8","article-title":"Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: A retrospective cohort study.","volume":"18","author":"Zilberberg","year":"2014","journal-title":"Crit Care"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF01712153","article-title":"Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group.","volume":"22","author":"Alvarez-Lerma","year":"1996","journal-title":"Intensive Care Med"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008.","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/CCM.0b013e3181fa41a7","article-title":"Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay.","volume":"39","author":"Shorr","year":"2011","journal-title":"Crit Care Med"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients.","volume":"115","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1097\/01.CCM.0000098031.24329.10","article-title":"Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.","volume":"31","author":"Garnacho-Montero","year":"2003","journal-title":"Crit Care Med"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","article-title":"Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.","volume":"115","author":"Harbarth","year":"2003","journal-title":"Am J Med"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1164\/rccm.200812-1912OC","article-title":"Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study.","volume":"180","author":"Ferrer","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1164\/rccm.201001-0094OC","article-title":"Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients.","volume":"182","author":"Esperatti","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/infdis\/jiy578","article-title":"Evidence-based study design for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.","volume":"219","author":"Talbot","year":"2019","journal-title":"J Infect Dis"},{"key":"R17-20240807","doi-asserted-by":"crossref","first-page":"200023","DOI":"10.1183\/16000617.0023-2020","article-title":"Is ventilated hospital-acquired pneumonia a worse entity then ventilator-associated pneumonia?","volume":"29","author":"Vallecoccia","year":"2020","journal-title":"Eur Resp Rev"},{"author":"Zilberberg","key":"R18-20240807","article-title":"Descriptive epidemiology and outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019. Crit Care Med 2022; 50:460-468"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/ice.2021.464","article-title":"Microbiology, empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2014-2019.","volume":"43","author":"Zilberberg","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.chest.2018.12.024","article-title":"A novel algorithm to analyze epidemiology and outcomes of carbapenem resistance among patients with hospital-acquired and ventilator-associated pneumonia: A retrospective cohort study.","volume":"155","author":"Zilberberg","year":"2019","journal-title":"Chest"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"e00346","DOI":"10.1128\/AAC.00346-20","article-title":"Antimicrobial susceptibility and cross-resistance patterns among common complicated urinary tract infections in U.S. hospitals, 2013 to 2018.","volume":"64","author":"Zilberberg","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"ofz504","DOI":"10.1093\/ofid\/ofz504","article-title":"Carbapenem treatment and outcomes among patients with culture-positive complicated intra-abdominal infections in US hospitals: A retrospective cohort study.","volume":"6","author":"Zilberberg","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"e87382","DOI":"10.1371\/journal.pone.0087382","article-title":"Using highly detailed administrative data to predict pneumonia mortality.","volume":"9","author":"Rothberg","year":"2014","journal-title":"PLoS One"},{"issue":"Suppl 3)","key":"R25-20240807","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1017\/S0899823X00194073","article-title":"Outcomes of patients with healthcare-associated pneumonia: Worse disease or sicker patients?","volume":"35","author":"Rothberg","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jhm.2199","article-title":"The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis.","volume":"9","author":"Lagu","year":"2014","journal-title":"J Hosp Med"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13756-017-0286-9","article-title":"30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: A retrospective cohort study.","volume":"6","author":"Zilberberg","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jhm.713","article-title":"Hospitalizations with healthcare-associated complicated skin and skin structure infections: Impact of inappropriate empiric therapy on outcomes.","volume":"5","author":"Zilberberg","year":"2010","journal-title":"J Hosp Med"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society.","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:22:26Z","timestamp":1723040546000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000667","relation":{},"ISSN":["2639-8028"],"issn-type":[{"type":"electronic","value":"2639-8028"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}